U.S. Hotel and Resort REITs Stock News

Phillips 66 ( NYSE:PSX ) shareholders (or potential shareholders) will be happy to see that the Independent Director...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

We wouldn't blame Green Brick Partners, Inc. ( NYSE:GRBK ) shareholders if they were a little worried about the fact...

NasdaqGS:FUNC 1 Year Share Price vs Fair Value Explore First United's Fair Values from the Community and select yours...

NasdaqCM:CISO 1 Year Share Price vs Fair Value Explore CISO Global's Fair Values from the Community and select yours...

NasdaqGS:SKYW 1 Year Share Price vs Fair Value Explore SkyWest's Fair Values from the Community and select yours We...

NYSE:ALV 1 Year Share Price vs Fair Value Explore Autoliv's Fair Values from the Community and select yours When close...

Maui Land & Pineapple Company ( NYSE:MLP ) Second Quarter 2025 Results Key Financial Results Revenue: US$4.60m (up 74...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Earlier this month, PROCEPT BioRobotics Corporation reported its second-quarter and first-half 2025 earnings, highlighting sales growth to US$79.18 million for the quarter and a narrowing net loss of US$19.58 million compared to the previous year. The company also raised its full-year 2025 revenue guidance to approximately US$325.5 million, reflecting confidence in sustained sales momentum and operational improvements. We'll now consider how this raised full-year revenue guidance could...

Millicom International Cellular S.A. recently reported its second quarter 2025 results, posting net income of US$676 million and basic earnings per share of US$4.05, despite a year-over-year decrease in sales to US$1.37 billion. This substantial rise in profitability, coupled with the approval of an interim dividend of US$2.50 per share, points to enhanced operational efficiency and strong shareholder returns even as revenues decreased. We’ll explore how robust earnings growth, even...

On August 14, 2025, Lufax Holding announced that Mr. Weidong Li resigned as independent non-executive director and key committee member, with Ms. Wai Ping Tina Lee appointed as his replacement to bolster board diversity in line with updated governance standards. Ms. Lee brings over four decades of legal and banking experience to the board at a time when regulatory changes are driving greater female representation in corporate leadership. We'll examine how the focus on enhanced board...

National Health Investors, Inc. recently reported its second quarter 2025 results, showing increases in revenue and net income compared to the previous year, alongside an announced quarterly dividend of US$0.92 per share payable on October 31, 2025. Although sales and revenue advanced year over year, basic and diluted earnings per share from continuing operations slightly declined for the quarter, highlighting a shift in earnings allocation or cost structure. We'll take a closer look at how...

ReNew Energy Global Plc recently reported its first quarter FY26 results, recording INR41.18 billion in revenue and a net profit of INR5.13 billion, both showing significant year-over-year increases. The company's clean power capacity grew by 23% and ReNew surpassed analyst revenue estimates, while also reiterating guidance for continued capacity and operational expansion. We’ll explore how ReNew’s robust profit jump and clean energy capacity growth may shape the company’s longer-term...

Liberty Broadband reported strong earnings for the second quarter ended June 30, 2025, with sales rising to US$261 million and net income increasing to US$383 million from the previous year. Despite not repurchasing any shares in the latest quarter, the company has completed a massive buyback program totaling nearly 34.2% of its outstanding shares since 2016, amounting to over US$8.1 billion. We’ll examine how Liberty Broadband’s significant year-over-year net income growth updates its...

Earlier this month, Oddity Tech Ltd. reported second quarter sales of US$241.14 million and net income of US$49.29 million, also raising its full-year 2025 net revenue guidance to a new range of US$799 million to US$804 million. This upward revision to revenue targets following robust quarterly results highlights the company’s confidence in its operating momentum and future demand outlook. We’ll explore how Oddity Tech’s strengthened full-year guidance, reflecting accelerating business...

Globus Medical reported strong second-quarter 2025 results, with sales of US$745.34 million and net income of US$202.85 million, along with reaffirmed full-year revenue guidance of US$2.80 billion to US$2.90 billion. The company completed a share buyback of 411,000 shares for US$24.99 million, signaling ongoing confidence in its capital allocation strategy. We’ll now explore how Globus Medical’s robust earnings growth and reaffirmed guidance influence its broader investment narrative. We've...

Ascendis Pharma released its second quarter and half-year 2025 financial results, reporting sales of €158.05 million and €259 million, respectively, with both periods showing sharply reduced net losses compared to the previous year. This marked improvement in revenue and narrowing of net loss highlights the company's progress toward greater financial stability and operational efficiency as of June 30, 2025. We'll explore how the substantial year-over-year revenue growth and reduced net loss...

CF Industries Holdings released its second-quarter 2025 results, reporting US$1.89 billion in sales, steady ammonia production, and updates on share repurchase activity completed under its ongoing buyback program. Notably, management issued full-year guidance projecting gross ammonia output to reach approximately 10 million tons, highlighting continued focus on production scale and operational efficiency. To understand the potential impact on CF Industries Holdings' investment outlook, we'll...

Harmony Biosciences Holdings recently reported second-quarter 2025 earnings, revealing net income of US$39.78 million versus US$11.59 million a year earlier and reaffirmed its full-year 2025 revenue guidance of US$820 million to US$860 million. This sharp improvement in earnings and maintained revenue outlook highlights the company’s operational momentum and management’s confidence in its ongoing business performance. With Harmony Biosciences delivering much higher profits and upholding its...

Grindr Inc. recently announced its second quarter 2025 earnings results, reporting sales of US$104.22 million and a net income of US$16.64 million, marking a shift from a net loss for the same period last year. This turnaround to profitability, alongside strong year-over-year revenue growth, reflects the company’s improved operational performance and shifting financial trajectory. Now, we’ll explore how Grindr’s return to profitability could influence its investment narrative and future...

Core Scientific reported its second quarter 2025 earnings on August 8, showing revenue of US$78.63 million compared to US$141.1 million a year earlier, with a net loss of US$936.8 million and basic loss per share from continuing operations of US$0.04. Despite continued year-over-year declines in revenue and net losses, major Wall Street analysts recently upgraded or reaffirmed positive ratings for the company after the earnings report. We’ll examine how improved analyst sentiment, following...

Earlier this month, Dynavax Technologies Corporation raised its full-year 2025 revenue guidance for HEPLISAV-B to a range of US$315 million to US$325 million and posted quarterly results showing second-quarter revenue climbed to US$95.44 million, with net income reaching US$18.72 million. The guidance increase reflects strong performance in the first half, while the earnings report highlights significant year-over-year growth in both revenue and profit margins for the company. To understand...

Earlier this month, V2X, Inc. filed for a follow-on equity offering of 2,000,000 shares of common stock shortly after reporting a return to profitability in its second-quarter results and reaffirming its full-year revenue guidance. This sequence of events highlights how the company is taking advantage of renewed financial momentum to strengthen its balance sheet through equity financing. We'll explore how V2X’s follow-on equity offering, coming right after its profitability turnaround, may...